Alnajashi, H. 2025. Rituximab as an off Label, High Efficacy Therapy in The Treatment of Multiple Sclerosis and Related Central Nervous System Demyelinating Diseases: Single Centre Experience and Literature Review. Journal of Contemporary Medical Sciences. 11, 3 (Jun. 2025). DOI:https://doi.org/10.22317/jcms.v11i3.1892.